Выбор редакции

Transcept shares sink as it expects FDA to again reject sleep

Bangalore (Reuters) - Shares of Transcept Pharmaceuticals Inc plummeted 42 percent in pre-market trade on Wednesday, a day after the specialty pharmaceutical company said it expects a second...


НОВОСТИ ПО ТЕМЕ